Related references
Note: Only part of the references are listed.Secreted immunoregulatory proteins in the skin
Katharina Noske
JOURNAL OF DERMATOLOGICAL SCIENCE (2018)
DUOX expression in human keratinocytes and bronchial epithelial cells: Influence of vanadate
Thomas Hill et al.
TOXICOLOGY IN VITRO (2018)
Off-target inhibition by active site-targeting SHP2 inhibitors
Ryouhei Tsutsumi et al.
FEBS OPEN BIO (2018)
The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis
Cristina Albanesi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Oncostatin M is overexpressed in skin squamous-cell carcinoma and promotes tumor progression
Marie Simonneau et al.
Oncotarget (2018)
Recent Progress in the Development of Transglutaminase 2 (TGase2) Inhibitors
Minsoo Song et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Spectrum of Autosomal Recessive Congenital Ichthyosis in Scandinavia: Clinical Characteristics and Novel and Recurrent Mutations in 132 Patients
Maritta Hellstrom Pigg et al.
ACTA DERMATO-VENEREOLOGICA (2016)
A novel protein tyrosine phosphatase 1B inhibitor with therapeutic potential for insulin resistance
Xiaolin Zhang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology
Heike M. Hermanns
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Inhibitors of tissue transglutaminase
Jeffrey W. Keillor et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Inhibition of Keratinocyte Differentiation by the Synergistic Effect of IL-17A, IL-22, IL-1α, TNFα and Oncostatin M
Hanitriniaina Rabeony et al.
PLOS ONE (2014)
Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity
Rosa M. Andres et al.
EXPERIMENTAL DERMATOLOGY (2013)
Signaling network of Oncostatin M pathway
Gourav Dey et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2013)
Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2
Kyle B. Johnson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
IFNγ mediates DUOX2 expression via a STAT-independent signaling pathway
Thomas Hill et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551
S. Fukuda et al.
DIABETES OBESITY & METABOLISM (2010)
Aryl vinyl Sulfonates and Sulfones as active site-directed and mechanism-based probes for protein tyrosine phosphatases
Sijiu Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Arsenite and insulin exhibit opposing effects on epidermal growth factor receptor and keratinocyte proliferative potential
Timothy J. Patterson et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation
Katia Boniface et al.
JOURNAL OF IMMUNOLOGY (2007)
Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor
Liwei Chen et al.
MOLECULAR PHARMACOLOGY (2006)
Arsenite maintains germinative state in cultured human epidermal cells
TJ Patterson et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Transcriptional responses of human epidermal keratinocytes to Oncostatin-M
N Finelt et al.
CYTOKINE (2005)
Identification of a nuclear Stat1 protein tyrosine phosphatase
J ten Hoeve et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Share Paper
